Clinical Trial Update: Liposomal Bupivacaine vs Ropivacaine for TAPBs [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating liposomal bupivacaine versus ropivacaine for TAP blocks in abdominal cancer surgery; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abdominal Cancer

Drugs mentioned

• Exparel (liposomal bupivacaine)
• Ropivacaine (Ropivacaine)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Abdominal Tumor, Postoperative Analgesia | Phase 3 | Status: RECRUITING